Miliani de Marval, Paula <br/><br/>
CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.  [electronic resource] 

 -  Cancer prevention research (Philadelphia, Pa.)  Jun 2011 
 - 851-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1940-6215 
<br/><br/><label>Standard No.: </label>10.1158/1940-6207.CAPR-10-0360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>9,10-Dimethyl-1,2-benzanthracene--toxicity<br/>Animals<br/>Carcinogens--toxicity<br/>Carcinoma, Squamous Cell--chemically induced<br/>Cysteine Endopeptidases--genetics<br/>Deubiquitinating Enzyme CYLD<br/>Disease Progression<br/>Epidermal Cells<br/>Epidermis--metabolism<br/>Humans<br/>Hyperplasia--metabolism<br/>Immunoblotting<br/>Immunoprecipitation<br/>JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Lymphatic Metastasis<br/>Mice<br/>Mice, Transgenic<br/>Mutation--genetics<br/>Proto-Oncogene Proteins c-fos--metabolism<br/>Proto-Oncogene Proteins c-jun--metabolism<br/>Skin Neoplasms--chemically induced<br/>Tetradecanoylphorbol Acetate--toxicity<br/>Transcription Factor AP-1--antagonists & inhibitors<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Proteins--genetics<br/>Ubiquitination